We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WBX:NYSEWallbox N.V. Analysis

Data as of 2026-08-01 - not real-time

$3.23

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Wallbox N.V. (WBX) trades at $3.23, comfortably above its 20‑day SMA of 4.41 but below the 50‑day SMA of 3.70, indicating a short‑term pull‑back within a broader uptrend (trend_direction: bullish). The RSI of 39 suggests the stock is approaching oversold territory, while the MACD histogram is negative (-0.206) and the signal line is bearish, pointing to lingering momentum weakness. Volume has been decreasing, and the 30‑day volatility is extremely high at 146 %, underscoring a risky price environment. Fundamentals are fragile: revenue fell 37.5% YoY, operating margin is a deep -46%, and both trailing and forward PE are negative, yet the price‑to‑sales ratio of 0.63 and a target upside of roughly 24 % (median target $3.9985) keep the valuation attractive on a relative basis. Recent news confirms a €10.65 million equity raise and a €4 million strategic investment, which should shore up the balance sheet after a recent compliance filing with the NYSE. Overall, the stock sits at a technical support near $3.00, faces substantial upside to the $6.18 resistance, but the combination of weak earnings, high beta (≈1.35) and volatile trading suggests caution.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI near oversold but MACD still bearish
  • Price hovering at technical support $3.00
  • Elevated 30‑day volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Equity raise and new strategic investment improve capital structure
  • Order intake up 11% expanding backlog
  • Target upside of ~24% to $3.9985

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Long‑term EV charging market tailwinds
  • Broad product suite covering residential to high‑speed public charging
  • Geographic diversification across Europe, North America and Asia

Key Metrics & Analysis

Financial Health

Revenue Growth-37.50%
Profit Margin-93.83%
P/E Ratio-1.2
P/B Ratio-1.6
Industry P/E32.8

Technical Analysis

TrendBullish
RSI39.2
Support$3.00
Resistance$6.18
MA 20$4.41
MA 50$3.70
MA 200$3.36
MACDBearish
VolumeDecreasing
Fear & Greed Index92.88

Valuation

Target Price$4.00
Upside/Downside23.79%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.35
Volatility146.43%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.